CBD and Your Health.

Similar documents
Medical Cannabis: A Patient Primer

Acknowledgements: What it is What it s not. Cannabis Evidence Series. Evidence-informed decision-making

I would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people

Medical Cannabis. Danial Schecter, MD, CCFP. Vocational Rehabilitation Association November 7th, Executive Director Cannabinoid Medical Clinic

Medical Marijuana for Pain How Does Cannabis Work on Your Body?

THE COMPLETE CBD GUIDE

Curious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD

World s most advanced PCR-CBD

CANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS

Objectives. 1. Review controversy 2. Pathophysiology 3. Indications for Use 4. Adverse Effects 5. How Patients Access

James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada

Consumer Information Cannabis (Marihuana, marijuana)

Outcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

CBD Oil: Benefits, Top Products, Where To Buy, And More

Act 16 and Medical Cannabis in Pennsylvania

Cannabis & Hemp therapeutic solutions

Medical Marijuana. 1. is a plant species, variety known as hemp. 3. Tetrahydrocannabinol is an aromatic with low water solubility.

Welcome to MedWell. MedWell Health and Wellness Centers. Don t live with PAIN Live WELL MedWell. o Newspaper o Referred by.

Medical Cannabis MATT WEBSTER DO, MS

ADVANCED CLINICAL CANNABINOID PROVIDER EXAM ACCP

MEDICAL MARIJUANA: WHAT S THE EVIDENCE?

CANNABIS FOR THE RHEUMATOLOGIST

Medical vs Recreational Use of Cannabis. 11 th December 2017

This questionnaire will ask you about approved medical use of extracts and tinctures of cannabis at national level.

Medicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system

CBD Oil: Anxiety Aid & Much More

POLICY NUMBER: POL 153

July 15 TH, ANDREW MEDVEDOVSKY, M.D. Board Certified Neurologist & Pain Medicine Specialist Director New Jersey Alternative Medicine

A look at Marijuana in 2014

DESCRIPTION DURATION

CANNABIS AND CANNABINOIDS: 2017 REPORT, U.S. NATIONAL ACADEMIES OF SCIENCES, ENGINEERING AND MEDICINE

Medical Marijuana Consent Form

Questionnaire 1 of 5: Cannabis Plant and Cannabis Resin. Introduction

Steven G. Kinsey, PhD Associate Professor, Department of Psychology West Virginia University

Introduction: You now have better information 2. What, How, Why?: CBD Basics 3 What is CBD? How does CBD work? Why take CBD?

Susan Audino, PhD S.A. Audino & Associates, LLC

OXZGEN FAQ s What is the Endocannabinoid System? What are cannabinoids? What is CBD oil?

Marijuana and Adolescents: Truth and Consequences. Disclosure Statement OBJECTIVES. Secondary Objectives. State of Marijuana in US

Research on Cannabis and PD: Is there any evidence?

Dr. G. Michael (Michael) Allan EDMONTON AB Dr. Christina (Tina) S. Korownyk EDMONTON AB MEDICAL CANNABANOIDS IN PRIMARY CARE

Medical Marijuana: The Move to Schedule II

Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids

Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids

Leading a budding industry into the future

MARIJUANA in MEDICAL CARE READY or RISKY. HINDI MERMELSTEIN, MD FAPM Beth Israel Medical Center, NYC Dec

PATIENT INTAKE FORM. Name: Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell:

Medical Cannabinoids for the Management of Chronic Noncancer Pain

Welcome to MedWell. Patient Information. Name: Address: City: State: Zip Code: !Other. Name: Address: City: State:

Life s brighter under the sun MEDICAL CANNABIS AND GROUP BENEFITS PLAN COVERAGE

CDHA 2016 Fall Symposium. Speaker Handout Files. For registered attendees only

Medicinal cannabinoids where does it fit in Palliative Care? Janet Hardy Phillip Good Georgie Cupples Matthew Spitzer

SUPER SNOUTS CBD150 & CBD300 OIL FOR DOGS & CATS

INITIAL PATIENT INTAKE FORM

Medical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center. Disclosure.

Medical Cannabis. Christine Yoshioka, NP

The Benefits and Uses of CBD Oil

Cannabis and What we Know. Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017

Medical Marijuana Update Chris Belletieri, DO


Use of Cannabinoids in Medical Practice

Is the most common illicit drug used in the United States. After a period of decline in the last decade, its use has been increasing among young

Susan Allen-Evenson Hosts: Laura Lagano, MS, RDN, CDN Prepare for the Next Level: Incorporating Holistic Cannabis in the Nutrition Practice

PREMIUM WHOLE-PLANT CANNABINOID HEMP EXTRACT CHARLOTTE S WEB. by the Stanley Brothers. Science Driven. Naturally Crafted. Family Trusted. cwhemp.

CANNABINOIDS: NOVEL MOLECULES WITH SIGNIFICANT CLINICAL UTILITY

MEDICAL CANNABIS IN MINNESOTA

MEDICAL CANNABIS QUICK REFERENCE GUIDE

MEDICAL CANNABIS IN MINNESOTA

The Endocannabinoid System

GARY GETTELFINGER MD HEMP-CBD OIL: POTENTIAL HEALTH BENEFITS

Cannabinoids: access and symptom management in cancer

Medical Marijuana: Hype versus Evidence

MEDICAL CANNABIS QUICK REFERENCE GUIDE

CHARLOTTE S WEB. cwhemp.com. Science Driven. Naturally Crafted. Family Trusted. by the Stanley Brothers

The Highs and Lows of Medical Marijuana

Cognitive Research Corporation

The Scientific Side of Medical Marijuana

The Company. Beyond Pioneering

History Of Medical Cannabis

Cannabinoids & Pain. the state of the art the state of the science. Insights from Academic and Industry leaders. Background on. Cannabinoids and Pain

Cannabis in the treatment of Autism:

CBD USER GUIDE CUREDNUTRITION.COM CBD INFUSED PRODUCTS MADE FROM COLORADO-GROWN ORGANIC HEMP

MOTION FOR A RESOLUTION

Medical Cannabis Program. Dr. Maureen Small Co Medical Director Andrea Sundberg Program Coordinator

Medical Marijuana in the Workforce. What This Is...And What It Isn t

Cannabis: Therapeutic properties of the plant

Cannabidiol as a potential treatment for anxiety disorders. Esther Blessing, MD PhD

Research: Medical Cannabis

Learning Objectives 1/8/2019. Therapeutic Potential of the Marijuana-Derived Cannabinoids THC and CBD. Disclosures. Outline. Take home messages

The Return of Medicinal Cannabis

Medical Marijuana. Speaker Disclosure Requirements. Share with a Partner 4/10/2015

Anti-inflammatory Cannabinoids without psycho-active side-effects

Cannabis. Member of the Cannabaceae family of flowering plants (along with hops) Cannabis sativa (v. sativa, indica, afghanica, ruderalis)

Marijuana and the Chronic Non-Cancer Pain Patient

full spectrum hemp products

How much do you know about illnesses or health problems for your parents, grandparents, brothers, sisters, and/or children? 1 A lot Some None at all

Agracan - LP. Palmerston Industrial Park Cannabis Cultivation Facility

HEALTH WELLNESS COMMUNITY

Reefer Madness version 3.0*

Transcription:

CBD and Your Health. Cannabidiol (CBD) is a molecule found in plant species such as agricultural (or industrial) hemp, and Echinacea. CBD is one of at least 489 distinct compounds within hemp: it is clear that cannabis and CBD are two entirely different things. Cannabidiol is a phytocannabinoid, it is not psychoactive and has anti-psychotic effects. Due to decades of old laws throughout most of the western world banning the cultivation or use of marijuana, clinical research into CBD and the human endocannabinoid regulatory system is not as advanced as might be expected. In fact, it might not be wrong to say that the endocannabinoid system has a leading role in one of the last great mysteries of how the human body works. Michelle Reillo, Ph. D and co-founder of ViPova TM has written that, The human endocannabinoid system is responsible for memory networks in the brain, both excitatory and inhibitory, including the neurogenesis of hippocampal granule cells, which regulate the timing of the endocannabinoids in accordance with the brain s needs, pain perception, mood, synaptic plasticity, motor learning, appetite and taste regulation, and metabolic function, which regulates the storage of energy and transport of cellular nutrition. CB1 receptors are located in the central and peripheral nervous systems as well as the lungs, kidneys, and liver. CB2 receptors are predominantly expressed in the immune system and hematopoietic cells.

There is a vast amount of research required to unlock the knowledge of precisely how CBD interacts with the endocannabinoid system; and how these influence or affect human health. But already, early indications are astonishing to many observers. Documented research has implicated the endocannabinoid system and/or cannabidiol to each of the following conditions: Alzheimer s disease and dementia Anxiety and Depression Appetite Asthma Cancer Cardiovascular function Digestion Epilespsy Fibromyalgia Glaucoma Headache and migraine Huntington s disease Immune function Inflammation Irritable bowel disease Liver disease Memory Metabolism and energy homeostasis Multiple Sclerosis Nausea and vomiting Neural development Neuropathic pain or chronic pain

Osteoarthritis and rheumatoid arthritis Osteoporosis Post-traumatic stress disorder Parkinson s disease Psychiatric disease Psychomotor behavior Schizophrenia and psychosis Spinal cord injury and disease Stress and emotional state regulation Tourette s Syndrome Wake/sleep cycles Wasting syndrome in AIDS and cancer patients The list is so comprehensive it is staggering. No claim has been made and no claim is being made that CBD cures any of these conditions or diseases. However, thousands of researches, usually working independently of each other, have discovered links or associations of some kind, between CBD or the endocannabinoid system, and each of these diseases or conditions. It seems clear that, with links or effects to such a widely varied group of conditions, the endocannabinoid system plays a central role in human health, even if that role is currently poorly understood. Perversely, much of the research to date has been conducted on cannabis, not necessarily with regard to which of the 485 compounds within the cannabis might be responsible for noted outcomes. The majority of such studies temper potential beneficial outcomes with remarks of the negative psychotropic effects that are often associated with tetrahydrocannabinol (THC). For example, following is a table summarizing various published clinical trials on smoked or vapourized cannabis: Table 7: Published Clinical Trials on Smoked/Vapourized Cannabis and Associated Therapeutic Benefits Percent and dose of Δ9- THC (if known) Trial duration; and number of patients/participants Reference

Primary medical conditions and associated secondary end-points (if any) for which benefits were observed HIV/AIDS-associated weight loss HIV/AIDS-associated weight loss; disease-associated mood and insomnia Multiple sclerosis-associated pain and spasticity Central and peripheral chronic neuropathic pain (various etiologies) Chronic neuropathic pain from HIV-associated sensory neuropathy HIV-associated chronic neuropathic pain refractory to other medications Chronic post-traumatic or post-surgical neuropathic pain refractory to other medications and associated insomnia Chronic pain of various etiologies (musculoskeletal, posttraumatic, arthritic, peripheral neuropathy, cancer, fibromyalgia, migraine, multiple sclerosis, sickle cell disease, thoracic outlet syndrome) mg) containing 1.8% or 3.9% THC by weight, smoked once daily (~14-31 mg Δ9-THC /day) mg) containing 2.0% or 3.9% THC by weight, smoked four times per day (i.e. 4 doses per day) (~64-125 mg of Δ9-THC /day) mg) containing 4% THC by weight, smoked once per day (~32 mg Δ9-THC /day) mg) containing either 3.5% or 7% THC by weight, smoked in bouts over a 3 h period 1 cannabis cigarette (~900 mg) containing 3.56% THC by weight, smoked three times daily (i.e. 3 doses per day) (~96 mg Δ9-THC /day) mg) containing between 1 and 8% THC by weight, smoked four times daily (i.e. 4 doses per day) One 25 mg dose of cannabis containing 9.4% THC by weight, smoked three times daily (i.e. three doses per day) (~7 mg Δ9-THC /day) One 0.9 g dose of vapourized cannabis containing 3.56% THC by weight administered three times per day (one dose the first day, three doses per day for next three days, one dose the last day) (~96 mg Δ9-THC /day) 8 sessions total (3 sessions per week); 30 participants 4 days total; 10 participants 3 days total; 30 patients 1 day total; 38 patients 25 patients 28 patients 21 patients 21 patients (166) (167) (188) (168) (142) (186) (172) (187) Much of the research conducted to date has been with animals or is laboratory research and is not based on human clinical studies. Pre-clinical animal studies may have predictive value but may not translate accurately from an animal species to humans. In

humans, there is also always the possibility of placebo effect, though that is not likely possible in animal studies. ViPova TM has formulated its tea to infuse CBD within lipids in order to provide a more comforting and bioavailable delivery to the human digestive system. It will take the collective work and research of thousands of highly trained professionals to determine whether there are actually any health benefits associated with ingesting CBD, and if so, how best to optimize CBD delivery. We do not know the answers today. But in the meantime, you have ViPova TM. Sources for this article: Information For Health Care Professionals, Hanan Abramovici, Ph.D., Health Canada, 2013 Mayo Foundation for Medical Education and Research, Michael Bostwick, February 2012 Scientists Uncover How CBD Treats MS, Alters Cholesterol Metabolism, FreedomIsGreen.com, Jahan Marcu, May 25, 2011 Journal of Pharmacology and Experimental Therapeutics, Alessia Ligresti et.al, 2006 Phytomedicine, Barbara Romano et al, 2013